Background and aims: The genotypic method could significantly shorten the time needed to
obtain antibiotic susceptibility data for Helicobacter pylori. The aim of this study was to …

Abstract Background Resistant Helicobacter pylori to commonly used antimicrobial agents
are associated with severe upper gastrointestinal disorders. To provide an epidemiological …

Background: The increasing prevalence of antimicrobial resistance, together with the lack of
novel treatment options, negatively affects successful eradication of Helicobacter pylori. The …

Background Helicobacter pylori susceptibility to clarithromycin and fluoroquinolone can be
determined through Etest or molecular assays. We examined the correlation between …

Purpose: The present study was done to assess the prevalence rate, antibiotic resistance
pattern and genotyping status of the Helicobacter pylori strains isolated from human and …

Abstract Background and Aim: Most clarithromycin‐resistant strains of Helicobacter pylori
have a mutation from adenine (A) to guanine (G) at position 2142 or 2143 of the 23S rRNA …

The high prevalence of antibiotic resistance in Helicobacter pylori has become a great
challenge in Iran. The genetic mutations that contribute to the resistance have yet to be …

Background Antimicrobial susceptibility testing (AST) plays a vital role in anti-Helicobacter
pylori treatment, but the traditional AST method has difficulty detecting heteroresistance …

Antibiotic resistance is now accepted as an inevitable factor in Helicobacter pylori treatment
failure, so a survey on the antibiotic susceptibility profile of H. pylori is welcomed. In addition …

Background/aims: Clarithromycin is an effective antibiotic for treating Helicobacter pylori;
however, the development clarithromycin-resistance by multiple strains prevents the …